Who makes Antangiogenesis?

Antangiogenesis is developed by Sun Yat-sen University.

Last reviewed 2026-04-19 · How we verify

Antangiogenesis

Sun Yat-sen University · Phase 1 active Small molecule

At a glance

Generic name	Antangiogenesis
Sponsor	Sun Yat-sen University
Modality	Small molecule
Therapeutic area	Other
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase I Trial of Intratumoral Injection of an Adenovirus Encoding Human Endostatin for Advanced Solid Tumors (Phase 1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Antangiogenesis CI brief — competitive landscape report
Antangiogenesis updates RSS · CI watch RSS
Sun Yat-sen University portfolio CI